These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 9388060

  • 21. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
    O'Neill CJ, Deavers MT, Malpica A, Foster H, McCluggage WG.
    Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
    [Abstract] [Full Text] [Related]

  • 22. Sertoli-stromal cell tumor of the ovary: immunohistochemical, ultrastructural, and genetic studies.
    Kato N, Fukase M, Ono I, Matsumoto K, Okazaki E, Motoyama T.
    Hum Pathol; 2001 Aug; 32(8):796-802. PubMed ID: 11521222
    [Abstract] [Full Text] [Related]

  • 23. Differences in follicular function of 3-month-old calves and mature cows.
    Driancourt MA, Reynaud K, Smitz J.
    Reproduction; 2001 Mar; 121(3):463-74. PubMed ID: 11226073
    [Abstract] [Full Text] [Related]

  • 24. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
    Ghanem MA, Van der Kwast TH, Den Hollander JC, Sudaryo MK, Oomen MH, Noordzij MA, Van den Heuvel MM, Nassef SM, Nijman RM, Van Steenbrugge GJ.
    Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
    [Abstract] [Full Text] [Related]

  • 25. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads.
    Cools M, Stoop H, Kersemaekers AM, Drop SL, Wolffenbuttel KP, Bourguignon JP, Slowikowska-Hilczer J, Kula K, Faradz SM, Oosterhuis JW, Looijenga LH.
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2404-13. PubMed ID: 16608895
    [Abstract] [Full Text] [Related]

  • 26. GATA-1 is a potential repressor of anti-Müllerian hormone expression during the establishment of puberty in the mouse.
    Beau C, Rauch M, Joulin V, Jégou B, Guerrier D.
    Mol Reprod Dev; 2000 Jun; 56(2):124-38. PubMed ID: 10813843
    [Abstract] [Full Text] [Related]

  • 27. Recent advances in the pathology and classification of gonadal neoplasms composed of germ cells and sex cord derivatives.
    Talerman A, Roth LM.
    Int J Gynecol Pathol; 2007 Jul; 26(3):313-21. PubMed ID: 17581418
    [Abstract] [Full Text] [Related]

  • 28. Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction.
    Ingraham HA, Hirokawa Y, Roberts LM, Mellon SH, McGee E, Nachtigal MW, Visser JA.
    Recent Prog Horm Res; 2000 Jul; 55():53-67; discussion 67-8. PubMed ID: 11036933
    [Abstract] [Full Text] [Related]

  • 29. Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo.
    Stephen AE, Pearsall LA, Christian BP, Donahoe PK, Vacanti JP, MacLaughlin DT.
    Clin Cancer Res; 2002 Aug; 8(8):2640-6. PubMed ID: 12171896
    [Abstract] [Full Text] [Related]

  • 30. [Molecular staging of testicular cancer using polymerase chain reaction of the testicular cancer-specific genes].
    Nonomura N, Imazu T, Harada Y, Nozawa M, Ono Y, Fukui T, Nishimura K, Okuyama A.
    Hinyokika Kiyo; 1999 Aug; 45(8):593-7. PubMed ID: 10500969
    [Abstract] [Full Text] [Related]

  • 31. Minimal antiproliferative effect of recombinant müllerian inhibiting substance on gynecological tumor cell lines and tumor explants.
    Wallen JW, Cate RL, Kiefer DM, Riemen MW, Martinez D, Hoffman RM, Donahoe PK, Von Hoff DD, Pepinsky B, Oliff A.
    Cancer Res; 1989 Apr 15; 49(8):2005-11. PubMed ID: 2702642
    [Abstract] [Full Text] [Related]

  • 32. Roles of estrogen receptor alpha (ER alpha) in the regulation of the human Müllerian inhibitory substance (MIS) promoter.
    Chen G, Shinka T, Kinoshita K, Yan HT, Iwamoto T, Nakahori Y.
    J Med Invest; 2003 Aug 15; 50(3-4):192-8. PubMed ID: 13678390
    [Abstract] [Full Text] [Related]

  • 33. Expression levels of Mullerian-inhibiting substance, GATA4 and 17alpha-hydroxylase/17,20-lyase cytochrome P450 during embryonic gonadal development in two diverse breeds of swine.
    McCoard SA, Wise TH, Ford JJ.
    J Endocrinol; 2002 Nov 15; 175(2):365-74. PubMed ID: 12429034
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin.
    Deavers MT, Malpica A, Liu J, Broaddus R, Silva EG.
    Mod Pathol; 2003 Jun 15; 16(6):584-90. PubMed ID: 12808064
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Gonadoblastoma: an immunohistochemical study and comparison to Sertoli cell nodule with intratubular germ cell neoplasia, with pathogenetic implications.
    Kao CS, Ulbright TM, Idrees MT.
    Histopathology; 2014 Dec 15; 65(6):861-7. PubMed ID: 24766183
    [Abstract] [Full Text] [Related]

  • 38. Detection of TSPY protein in a unilateral microscopic gonadoblastoma of a Turner mosaic patient with a Y-derived marker chromosome.
    Hildenbrand R, Schröder W, Brude E, Schepler A, König R, Stutte HJ, Arnemann J.
    J Pathol; 1999 Dec 15; 189(4):623-6. PubMed ID: 10629567
    [Abstract] [Full Text] [Related]

  • 39. Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo.
    Kurian MS, de la Cuesta RS, Waneck GL, MacLaughlin DT, Manganaro TF, Donahoe PK.
    Clin Cancer Res; 1995 Mar 15; 1(3):343-9. PubMed ID: 9815990
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.